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NeurosteroidsAlterations in GABAA receptor expression have been associated with the allopregnanolone (3α-hydroxy-
5α-pregnan-20-one; 3α,5α-THP) antidepressant-like effect in rats. The present study aimed to verify the effect
of bilateral, intra-nucleus accumbens core (intra-AcbC) administration of the neurosteroid allopregnanolone on
behaviors in the forced swim and grooming microstructure tests and in the δ and γ2 GABAA receptor subunit
mRNA expression in right and left hippocampus of rats. The results of this study showed that bilateral,
intra-AcbC allopregnanolone administration (5 μg/rat) presented antidepressant‐like activity in the forced
swim test concomitant with an increase in climbing. Allopregnanolone at doses of 1.25 and 5 μg/rat also de-
creased the percentage of correct transitions in the grooming microstructure test. Both δ and γ2 GABAA subunit
expressions increased in the rat hippocampus after allopregnanolone intra-AcbC treatment. Our ﬁndings point to
asymmetrical GABAA receptor expression changes in the hippocampus of animals treatedwith allopregnanolone.
Further investigation should evaluate the antidepressant-like effect of allopregnanolone not only in other direct-
ly infused regions but also with respect to changes in other brain areas of the limbic system to understand
allopregnanolone's mechanism of action.
© 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Neuroactive steroids are important endogenous modulators of
depressive and anxiety-related behaviors (Schüle et al., 2011).
Indeed, allopregnanolone and other neurosteroids, such as
dehidroepiandrosterone, pregnenolone (Schüle et al., 2011) and
pregnenolone-derivatives (Bianchi and Baulieu, 2012) have been im-
plicated with antidepressant-like effect in rodents. Allopregnanolone
(3α-5α-tetrahydroprogesterone; 3α-5α-THP; ALLO), a positive
modulator of the GABAA receptor (Paul and Purdy, 1992), is de-
creased in the cerebrospinal ﬂuid (Uzunova et al., 1998) and plasma
(Romeo et al., 1998; Strohle et al., 1999) of depressive patients.
Furthermore, clinically effective treatment with antidepressants is
correlated with increased levels of allopregnanolone in the plasma
of depressive individuals (Romeo et al., 1998; Strohle et al., 1999).
Likewise, preclinical studies show that allopregnanolone is decreased
in speciﬁc brain areas of the olfactory bulbectomized rat model of de-
pression compared with sham-operated rats (Uzunova et al., 2003).. Nin).
vier OA license.Moreover, there is an increase in allopregnanolone levels in mouse and
rat brain after subchronic antidepressant treatment (Grifﬁn and
Mellon, 1999; Nechmad et al., 2003). The intracerebroventricular ad-
ministration of allopregnanolone shows an antidepressant-like effect
in the forced swim test (Khisti et al., 2000) and learned helplessness an-
imal models of depression (Shirayama et al., 2011). The idea that
allopregnanolone is one of the most important neurosteroids involved
in the antidepressant effect of drugs has been conﬁrmed by the admin-
istration of ﬁnasteride. This 5α-reductase inhibitor, decreases the con-
version of progesterone to 5α-dehydroprogesterone and subsequently
to allopregnanolone, and increases immobility behaviors in the forced
swim test (Beckley and Finn, 2007).
Limbic brain regions are implicated in mood disorders and studies
point to the nucleus accumbens as an important area for emotional con-
trol (Sheline, 2003). The nucleus accumbens has extensive input from
and output to other limbic areas, such as the hippocampus (Goto and
O'Donnell, 2001; Nauta et al., 1978). Because there is an inverse correla-
tion between hippocampal allopregnanolone levels and depressive-like
behavior in female rats it has been supposed that the hippocampus is im-
plicated in the antidepressant effect of this neurosteroid (Frye andWalf,
2002, 2004). Indeed, intra-hippocampal infusion of allopregnanolone
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Furthermore, when administered into the nucleus accumbens,
allopregnanolone also reduces immobility duration in rats (Molina-
Hernandèz et al., 2005), leading to the conclusion that there might be
more than one brain areas related to the antidepressant effects of
neurosteroids or that the allopregnanolone infusion in a certain limbic
area may evoke GABAergic system alteration in the hippocampus.
GABAA receptor function is modulated by GABA and also by
benzodiazepines, barbiturates, convulsants and neurosteroids, in-
cluding allopregnanolone (Compagnone and Mellon, 2000). After
intrahippocampal allopregnanolone administration, mRNA expres-
sion of the γ2 GABAA receptor subunit increases in the hippocampus
of rats during the forced swim test (Nin et al., 2008), and expression
of the δ subunit increases in the CA1, CA3 and dentate gyrus regions
of the hippocampus after social isolation in mice (Serra et al., 2006).
The socially isolated mouse model evokes behavioral deﬁcits that are
comparable to those of depression (Pinna et al., 2003, 2004). These
deﬁcits are associated with decreases in allopregnanolone levels in
several brain areas (Pinna et al., 2003, 2006) and can be normalized
with antidepressant treatment (reviewed in Pinna, 2010). Different
stress models in rodents increase not only corticosterone, but also
depressive-like behaviors in the forced swim test that are reversed
by antidepressant treatment (Rayen et al., 2011; Viana et al., 2008;
Weathington et al., 2011). Grooming is an important part of rodent
behavior that can be induced by exposure to a new environment.
This behavior represents a complex sequence of patterns sensitive to
GABAergic drugs (Barros et al., 1992; Nin et al., 2012), and grooming
is a predictor of stress-like behavior (Kalueff and Tuohimaa, 2005).
The regulation of negative emotions in normal humans depends on
hemispheric asymmetries: left frontal activation is related to the volun-
tary suppression of negative emotions, and the right frontal area is
connected to spontaneous negative emotional responses (Jackson
et al., 2000). Several changes in brain asymmetry for certain brain
areas have been detectedwith neuroimaging inmood disorder patients
(Soares andMann, 1997), including patients withmajor depressive dis-
orders (Lacerda et al., 2003). Patients with bipolar disorder and depres-
sion show motor, perceptual and emotional functional disturbances
associated with interhemispheric asymmetries in many brain regions,
reinforcing the hypothesis that an asymmetric component may be crit-
ical for mood regulation (Caligiuri et al., 2004; Jackson et al., 2003;
Tranel et al., 2002). There are hemispheric asymmetries in biochemical
markers in animals subjected to unpredictable tones and shocks
(Orman and Stewart, 2007), which may trigger coping problems in
these animals that are associated with stressful stimuli (Sullivan,
2004). In a study from our laboratory, in rats, we observed that follow-
ing allopregnanolone treatment, antidepressant-like effects and higher
mRNA expression of theγ2GABAA subunit the right hippocampus com-
pared to the left hippocampus were detected (Nin et al., 2008).
Our present study was designed to determine the antidepressant
and antistress-like effects of intra-nucleus accumbens infusion of
allopregnanolone in rats and to quantify the hippocampal δ and γ2
GABAA receptor subunits expression in these animals, correlating
the behaviors observed with the biochemical data.
2. Methods and materials
2.1. Animals
Male Wistar rats (250–280 g; 90–110 days; n=42) were obtained
from the Animal House of Universidade Federal de Ciências da Saúde
de Porto Alegre (UFCSPA). Before surgery, the animals were housed in
groups of ﬁve in polypropylene cages with wood shavings as bedding.
After surgery, the animals were maintained in isolated cages
(25×35×35 cm in height). Food and water were available ad libitum,
and the animals were maintained in a temperature-controlled room
(22±2 °C) under a light–dark cycle (lights on from 7 am–7 pm). Allin vivo experiments followed the guidelines of the International Council
for Laboratory Animal Science and were approved by the Ethical Com-
mittee for Research of UFCSPA (557/08). All efforts were made to min-
imize animal suffering and to use only the number of animals necessary
to produce reliable scientiﬁc data.
2.2. Treatments
Immediately before administration, allopregnanolone (Sigma-Aldrich,
St. Louis, MO, USA) was dissolved in a 20% (w/v) 2-hydroxypropyl-
β-cyclodextrin (Fluka-Sigma-Aldrich, St. Louis, MO, USA) solution
prepared in artiﬁcial cerebrospinal ﬂuid (ACSF) (NaCl 147 mM; CaCl2
2.3 mM;KCl 4 mM;MgCl2 0.9 mM;pH7.1–7.3) to obtain a concentration
of 1.25 μg/μL, 2.25 μg/μL and 5 μg/μL. These doses showed
antidepressant-like effects when infused in the hippocampus (Nin
et al., 2008), and similar doses do not affect locomotion when infused
in the nucleus accumbens and in the hippocampus of rats (Molina-
Hernandèz et al., 2005; Rodríguez-Landa et al., 2009). The vehicle, in-
fused in the control rats (0 μg/rat), was the 20% 2-hydroxypropyl-
β-cyclodextrin ACSF solution. The animals were randomly divided
into four subgroups. Allopregnanolone (1.25, 2.5, or 5 μg/rat) or vehicle
were infused in each hemisphere in a volume of 0.5 μL per rat. The so-
lutions were infused at a constant rate of 0.25 μL/min through a
microperfusion pump (CMA/102. Acton; Harvard Apparatus, Holliston,
MA, USA) connected to a 27-gauge needle that was introduced
0.2 mm below the end of the guide cannula. To avoid reﬂux, the injec-
tion needles were removed from the guide cannula 2 min after the
end of the infusions. Allopregnanolone or vehicle solution was bilat-
erally administered three times: 24, 5 and 1 h before the test section
of the behavioral tests. The same animals were used for all of the be-
havioral and biochemistry experiments. Each experimental group
included 10–11 rats for the behavioral data and 6–9 rats for the bio-
chemical data.
2.3. Surgery procedure
The rats were anesthetized with xylazine HCl (5 mg/kg) and keta-
mine HCl (100 mg/kg) i.p. and placed in a stereotaxic frame (David
Kopf Instruments, Tujunga, CA, USA). Bilateral cannulae were placed
in the nucleus accumbens core (anteroposterior: +1.6 mm from breg-
ma; lateral: ±1.8 mm from bregma; vertical: −6.6 mm from dura
mater according to Paxinos andWatson, 1998). The nucleus accumbens
core was chosen because it is an area related to selection and integra-
tion of the limbic inputs that acquire control over motivation, discrete
cues and learning (Ito and Hayen, 2011) which are considered impor-
tant in depression. Although the surgery procedure to introduce the
cannulae may provoke injuries, it is minimal, since the cannulae tres-
passes vertically the beginning of the hippocampus, leaving most part
of it intact (Paxinos and Watson, 1998). The endpoints of the cannulae
were 0.2 mm under the target, and the infusion areas are presented in
Fig. 1. The cannulae were ﬁxed to the skull with two screws and dental
cement. The surgeries were performed 7±2 days prior to the training
day component of the tests.
2.4. Grooming microstructure test
Forty-ﬁve minutes after the last treatment dose, the animals were
subjected to the behavioral tests. For grooming analyses, the animals
were placed inside a cylinder with a diameter of 20 cm surrounded
by 30-cm high white walls and a transparent ﬂoor. A camera placed
10 cm below the apparatus ﬂoor was used to record animals' behaviors
and provide a detailed record of activity. The test comprised of two sec-
tions 24 h apart: training (15 min) and test (15 min), both of which
were performed between 1 and 5 pm. In both sections, each rat was
placed in the center of the cylinder. Only the test section was recorded.
The testing room was illuminated by a dim light (25 W), and the
Fig. 1. A schematic representation of microinjection sites within the nucleus
accumbens core in +1.5 mm; +1.6 mm and +1.7 mm from bregma.
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analysis of grooming behaviors was performed and consisted of the
number of bouts (NBs) (previously called frequency of grooming),
latency to start grooming, and total time of grooming (TTG) (Barros
et al., 1994; Kalueff and Tuohimaa, 2005). The modiﬁed grooming mi-
crostructure analysis wasmeasured by the grooming actions sequence:
(1) paw licking, (2) snout washing, (3) head washing, (4) body
grooming/scratching, (5) hind legs and genital washing, and (0) no
grooming (Kalueff and Tuohimaa, 2005). An action, scored in number
of actions (NA), refers to any one the behaviors numbered above, ex-
cept for “0-no grooming”. The quantiﬁcation of the grooming action se-
quence was performed using an algorithm for posterior analysis
(Kalueff and Tuohimaa, 2004, 2005). A bout, quantiﬁed as the number
of bouts (NBs), is a single action that is interrupted by a no-grooming
action (0) for at least 3 s, or a sequence of actions until they are
interrupted. A complete bout (CB) consists of the following sequence
of actions: 0–1–2–3–4–5–0; or a shorter one: 1–2–3–4–5. The follow-
ing parameters were also determined: the number and percentage of
complete bouts (NCBs) and incomplete bouts (NIB=NB−NCB), aver-
age duration of a bout (ADB), average duration of an action (ADA) and
average number of transitions per bout (ANT=NA/NB). In addition, the
number of correct transitions (CT) (0–1; 1–2; 2–3; 3–4; 4–5; 5–0),
the number of incorrect transitions (IT, any other transitions), the
total number of transitions (NT) and the percentage of correct
(%CT=CT/NT) and incorrect transitions (%IT=IT/NT) were also ana-
lyzed, according to Kalueff and Tuohimaa (2005).
2.5. Forced swim test
Immediately after the grooming test, the animals were subjected
to the forced swim test. The procedure followed a slightly modiﬁed
Porsolt forced swim test protocol (Detke et al., 1995). All behavioral
tests were performed between 12 pm and 4 pm. Brieﬂy, the animals
were individually placed in cubic glass pools (25×25×40 cm) ﬁlled
with 30 cm of water at a temperature of 25(±1) °C. Although the
cylindrical pool is classically used for the forced swim test, the cubic
swimming pool was demonstrated to have the same sensitivity to de-
tect the antidepressant effect of drugs and has been used as a model
in our group and by other researchers (Ferigolo et al., 1998; Gomez
et al., 2003; Molina-Hernandèz et al., 2005; Nin et al., 2008). Two
swim sections were conducted: an initial 15 min training section
followed 24 h later by a 5-min test session. Following both sessions,
the rats were removed from the pools, carefully dried with towels,placed in a heated room for 15 min and later returned to their
home cages.
The frequency and duration of acts and postures (climbing, swim-
ming, diving, head-shakes, total mobility and immobility, and latency
to immobility) were detailed for each animal during the analysis of
the 300 s in the test day section. The behavioral analyses were de-
scribed previously and the model showed both reliability and validity
for detecting the antidepressant effects of noradrenergic, serotoniner-
gic, dopaminergic and GABAergic drugs in the forced swim test
(Detke et al., 1995; Ferigolo et al., 1998; Miura et al., 1996; Nin
et al., 2008). All of the behavioral analyses were video-recorded and
were analyzed by the same observer, who was blind to the animal
group allocation. The behaviors of interest were quantiﬁed using the
software program qbasic-wabehave written in BASIC (Kevin
Willioma, KD Ware Computer, Boston, MA, USA).
2.6. Cannulae placement veriﬁcation and structures removal
At the end of the behavioral testing, the animals were euthanized by
decapitation. The brains were rapidly removed, frozen in liquid nitro-
gen and stored in a freezer at−80 °C. After brieﬂy thawing, the brains
were sectioned using a rat brain slicer 1.0 mm (Zivic, Pittsburgh, PA,
USA) into the cannula incision area and photographed for posterior
placement analysis (Samsung™–DigimaxV5), which was followed by
hippocampus removal. Only animals with accurately placed cannulae
were considered for neurochemical and behavioral analysis. Correct
cannulae placementwas veriﬁed in 42 of the 49 animals that were sub-
mitted to surgery: vehicle (n=11), 1.25 μg/rat (n=11), 2.5 μg/rat
(n=10) and 5 μg/rat (n=10).
2.7. Real-time RT-PCR
The analysis of the relative gene expression of the γ2 and δ GABAA
subunit receptors in both hippocampus of each hemisphere was
performed using reverse transcription combinedwith real-time quanti-
tative PCR (qPCR) and the 2−ΔΔCT method (Livak and Schmittgen,
2001). For hippocampal gene expressions 6 to 9 samples were used,
randomly chosen from the animals submitted to the behavioral proto-
cols. Total RNA was extracted from each hemisphere of the hippocam-
pus using the Trizol™ Isolation Reagent Kit (Life Technologies,
Carlsbad, CA, USA) according to the manufacturer's instructions. All
RNA samples were resuspended in 50 μL of DEPC-treated water (Life
Technologies, Carlsbad, CA, USA) and stored at −80 °C. The cDNA
was synthesized from 9 μL of each RNA sample using SuperScript III
(Life Technologies, Carlsbad, CA, USA). The quantiﬁcation was made
by spectrophotometry using a Nanodrop (Thermo Fisher Scientiﬁc,
Wilmington, DE, USA). qPCR analysis was performed at least in dupli-
cate using the StepOnePlus Real-Time PCR System (Life Technologies,
Carlsbad, CA, USA). The set of δ and γ2 GABAA subunit and β-actin
(endogenous control) primers was determined based on Rattus
norvegicus data from the National Center for Biotechnology Information
(Table 1). The reaction contained 50 ng of cDNA, 2xPower SYBR Green
PCR Master Mix (Life Technologies, Carlsbad, CA, USA) and 0.17 μM of
each primer. The genes were ampliﬁed with an initial denaturation at
95 °C for 10 min followed by 40 cycles at 95 °C for 15 s and 60 °C for
1 min and were succeeded by the melting curve stage (Table 1).
2.8. Statistical analysis
A one-way ANOVA was used to determine if there were effects of
the different doses of allopregnanolone on the behavior of rats sub-
mitted to the forced swim and microstructure grooming tests. A
two-way ANOVA was used to compare the right and left hemisphere
mRNA expression and allopregnanolone treatments. Tukey's post-hoc
test was used when appropriate. Pearson's correlation was used to
verify if there was any association between behaviors in the forced
Table 1
Characteristics of primers used for ampliﬁcation.
Primer Sequence Size
(bp)
TM GenBank
b-actin (sense) 5′-TATGCCAACAC
AGTGCTGTCTGG-3′
205 82.2 °C NM_031144.2
b-actin (antisense) 5′-TACTCCTGCTTG
CTGATCCACAT-3′
δ (sense) 5′-AGCAGTGCCT
GCCAGAGTAT-3′
563 84.4 °C NM_017289.1
δ (antisense) 5′-CATGTAAAGC
CGTCATGTGG-3′
γ2 (sense) 5′-GACGATGACC
ACTCTCAGCA-3′
402 80.1 °C NM_177408.5
γ2 (antisense) 5′-ACAGTCCTTG
CCATCCAAAC-3′
TM, melting temperature; bp, base pairs; δ or γ2, delta or gamma-2 GABAA receptor
subunit, respectively; GenBank and accession numbers are available at http://
www.ncbi.nlm.nih.gov/.
Fig. 2. Effect of allopregnanolone (ALLO) infusion in the nucleus accumbens on behaviors i
doses of 1.25, 2.5 or 5 μg/rat, 24, 5 and 1 h before the behavioral tests. Forced swim test a
(D). Grooming microstructure test: grooming frequency (E) and percent of correct transit
one-way ANOVA and Tukey's test when appropriate. ⁎Pb0.05, ⁎⁎Pb0.01 compared with th
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presented as the mean±standard error of the mean (S.E.M.). Differ-
ences were considered signiﬁcant at Pb0.05.
3. Results
3.1. Effects of allopregnanolone on forced swim test behavior (see Fig. 2)
Intra-nucleus accumbens infusion of allopregnanolone decreased
the immobility time [F(3,38)=3.36, P=0.029; Fig. 2A] of rats submitted
to the forced-swimming which demonstrates its antidepressant-like
effect. Allopregnanolone-treated animals at the 5 μg/rat dose spent
36% less time in immobile-like behaviors than control rats (control:
202.0±48.0; ALLO 5 μg/rat: 129.1±63.6; P=0.019). This decrease of
immobility is concomitant to enhanced climbing behavior [F(3,38)=
4.26, P=0.011; Fig. 2B] at the same dose (P=0.007), without any dif-
ferences in the swimming time [F(3,38)=0.69, P=0.561]. Also, then the forced swim and grooming microstructure tests. ALLO was bilaterally infused at
nalysis: immobility (A), climbing (B), latency to start immobility (C) and head-shake
ions (F). Each bar represents the mean±S.E.M. The comparisons were made using a
e control group.
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[F(3,38)=3.20, P=0.039; Fig. 2C] with the allopregnanolone 5 μg/rat
group differing from the control group (P=0.035). Another behavior
thatwas decreased by the 5 μg/rat allopregnanolone treatmentwas fre-
quency of head-shakes [F(3,38)=3.06, P=0.040; Fig. 2D] compared
with the control group (P=0.035). Therewere no statistical differences
in behaviors after intra-nucleus accumbens administration of
allopregnanolone at doses of 1.25 or 2.5 μg/rat.
3.2. Effect of allopregnanolone on grooming microstructure test behavior
Allopregnanolone infusion did not alter classical groomingmeasure-
ments, such as the total time of grooming, frequency of grooming
(Fig. 2E) or latency to start grooming. Nevertheless, allopregnanolone
infusion changed grooming microstructure parameters. In fact, the
intra-nucleus accumbens infusion of allopregnanolone decreased the
percentage of correct transitions [F(3,29)=3.82, P=0.023; Fig. 2F]
when the allopregnanolone 1.25 μg/rat (P=0.044) and 5 μg/rat groups
(P=0.039)were comparedwith the control group. In addition, the per-
centage of incorrect transitions was changed because it is complemen-
tary to the percentage of correct transitions. No other statistical
differences were observed in the microstructure grooming test after
allopregnanolone treatment.
3.3. GABAA subunit mRNA expression after allopregnanolone infusion
The main purpose of this experiment was to determine if
allopregnanolone infused in the nucleus accumbens would alter the
GABAA subunit expression in the hippocampus, which could explain
the decrease in forced swim test immobility. Allopregnanolone infu-
sion in the nucleus accumbens altered mRNA expression of the δ
GABAA subunit in the hippocampus, depending on the hemisphere an-
alyzed [F(3,56)interaction=3.27, P=0.028; Fig. 3A]. Treatment with
5 μg/rat allopregnanolone increased δ expression compared with the
control group, only in the right hemisphere (controlright: 1.21±0.31;
ALLO 5 μg/ratright: 5.99±0.95; Pb0.001), which was also higher than
the left hippocampal hemisphere at the same dose (ALLO 5 μg/ratleft:
1.02±0.23; Pb0.001). Considering the other GABAA receptor subunit
tested, γ2, the proﬁle was almost identical, with a signiﬁcant interac-
tion being observed between the treatment and the hemisphere
[F(3,56)interaction=3.52, P=0.023; Fig. 3B]. Rats treated with 5 μg/rat
allopregnanolone showed an increase in γ2 subunit expression in
the right hemisphere compared with the left hemisphere (ALLO
5 μg/ratleft: 0.60±0.14; ALLO 5 μg/ratright: 2.3±0.52; Pb0.001) and
with the control treatment (controlright: 1.17±0.23; P=0.029).
There was no signiﬁcant correlation between the major parametersFig. 3. Effect of allopregnanolone (ALLO) infusion in the nucleus accumbens on GABAA recep
according to real-time RT-PCR. The treatments with ALLO 1.25, 2.5 or 5 μg/rat were bilatera
The comparisons were made using a two-way ANOVA and Tukey's test when appropriat
###Pb0.001 compared with the same treatment group in the other hemisphere.of the forced swim and grooming microstructure tests and the bio-
chemical data.
4. Discussion
In this study, allopregnanolone produced an antidepressant-like ef-
fect in rats after intra-nucleus accumbens core infusion (5 μg/rat), as
evaluated by the forced swim test. The region-speciﬁc effect of
allopregnanolone has been described to be dependent on the depres-
sive animal model used (Shirayama et al., 2011; Uzunova et al., 2004).
Although our study describes a speciﬁc coordinate targeting the core
of the nucleus accumbens, we may assume that allopregnanolone solu-
tion diffuses to adjacent shell region. A whole brain effect, as observed
with intracerebroventricular allopregnanolone treatment, induces
an antidepressant-like state in the learned helplessness model
(Shirayama et al., 2011). More speciﬁcally, some areas seem to play a
major role in this effect, such as the hippocampus, in which the admin-
istration of allopregnanolone decreases depressive-like behavior, as
evaluated by the forced swim test (Nin et al., 2008; Rodríguez-Landa
et al., 2009). Curiously, there is an antidepressant-like effect of
allopregnanolonewhen infused in the CA3 region but not in the dentate
gyrus, as evaluated by the learned helplessness rat model (Shirayama
et al., 2011). The antidepressant-like effect of allopregnanolone infused
in the nucleus accumbens shown in this study was not observed in the
learned helplessness rat model when it was tested at smaller doses
(1.0 and 0.1 μg/rat) than in this study (Shirayama et al., 2011). In addi-
tion, there was no antidepressant-like effect of allopregnanolone infu-
sion in the dorsal region of the prefrontal cortex or the caudatum
putamen nucleus in the forced swim test at the same doses used in
the present study (unpublished results).
Paralleling these results, it has been observed that in the olfactory
bulbectomized rat animal model of depression, there is a decrease in
allopregnanolone levels in the amygdala, frontal cortex and hippocam-
pus (Uzunova et al., 2003). The nucleus accumbens has extensive input
from and output to different limbic areas, such as the hippocampus
(Goto and O'Donnell, 2001; Nauta et al., 1978), and its main neuronal
cell type is themedium spiny neuron, which is a GABAergic neuron. Nu-
cleus accumbens core and shell receive different afferent projections
(Groenewegen et al., 1999), and some brain regions project to both
the nucleus accumbens core and shell (Voorn et al., 2004; Fields et al.,
2007; Humphries and Prescott, 2010). Consequently, nucleus
accumbens core and shell neurons could encode similar information
but have different effects on behavior depending on the downstream
regions they innervate. For instance, the transection or stimulation ofﬁ-
bers which carry hippocampal afferent information to the nucleus
accumbens, result in disappearance or induction, respectively, of the
more depolarized state in nucleus accumbens neurons (O'Donnell andtor expression in the hippocampus. (A) δ and (B) γ2 mRNA GABAA subunit expression
lly measured in the left and right hemispheres. Each bar represents the mean±S.E.M.
e. ⁎Pb0.05, ⁎⁎⁎Pb0.001 compared with the control group in the same hemisphere.
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(2001) described electrical ensembles between hippocampus and
nucleus accumbens neurons. The role of the hippocampus in the
antidepressant-like effects of allopregnanolonewas conﬁrmed by a pre-
vious study from our group, when the hippocampal infusion of
allopregnanolone decreased the depressive-like state in rats (Nin
et al., 2008). Therefore, beyond the idea that the antidepressant
effect may be region-speciﬁc, it is also plausible that increases in
allopregnanolone through an endogenous mechanism or by exogenous
infusion in one speciﬁc brain area could project its activity to some
other functionally connected brain area, as was observed in this study.
Climbing behavior during the forced swim test is used as amarker for
the norepinephrine activity in the central nervous system altered by an-
tidepressants (Detke, et al., 1995). Interestingly, a climbing increase was
previously observed after allopregnanolone treatment in rats, with no
change in swimming behavior (Molina-Hernandèz et al., 2005; Nin et
al., 2008). Until now, there are no descriptions of differential behavioral
changes in the forced swim test induced by GABAergic drugs that have
antidepressant-like effects. The anti-immobility effects of several
GABAergic agents (Khisti et al., 2000; Skirzewski et al., 2011) or agents
that change neurosteroid levels in the brain (Espallergues et al., 2012)
have been reported without measuring other behaviors usually ob-
served during the test. Therefore, we may speculate that this increase
in climbing would also be observed with GABAergic drugs. In contrast
to climbing behavior, there was a decrease in the head-shake behavior
when allopregnanolonewas infused in the nucleus accumbens; howev-
er, this behavior was not observed when allopregnanolone was infused
in the hippocampus (Nin et al., 2008). Although head-shake behavior is
known to be a typical serotoninergic-associated effect (Benekareddy
et al., 2010; Willins and Meltzer, 1997), changes in this behavior could
also be due to activity in the GABAergic system (Vargas et al., 1996,
1998). This pattern of effects was also observed after treatment with
non speciﬁc antidepressants, like imipramin (Barros and Ferigolo,
1998; Ferigolo et al., 1998).
Stressful situations, as occur in the socially isolated mouse model,
evoke behavioral deﬁcits that are analogous to depression (Pinna,
2010). Interestingly, allopregnanolone levels are also decreased in
the corticolimbic structures of this socially isolated mouse model
(Agis-Balboa et al., 2007; Pinna et al., 2003, 2006). Chronic treatment
with corticosterone, mimicking stressed animal levels, alters
GABAergic function in the hippocampus of rats (Orchinik et al.,
1995). Moreover, stress induced by the forced swim test produces
ﬂuctuations in the GABA levels of animals (Gomez et al., 2003;
Skirzewski et al., 2011), and certain antidepressants, such as paroxe-
tine, can decrease the levels of corticosterone (Linthorst and Reul,
2008). Stress induction, such as the exposure to a new environment,
induces grooming behavior, which can be observed early after
moving the animal from its cage to a new arena or when the animal
is exposed to other stressors (Bindra and Spinner, 1958; Kalueff and
Tuohimaa, 2005). Moreover, the grooming microstructure test
seems to be a more sensitive tool to detect stress-like situations
in rodents than the classical grooming parameters (Kalueff and
Tuohimaa, 2004, 2005). In the present study, it was observed that
allopregnanolone (1.25 and 5 μg/rat) treatment reduced the percentage
of correct transitions, which is described as a predictor of stress-like be-
havior (Kalueff and Tuohimaa, 2005). First, we hypothesized that
allopregnanolone would increase the percentage of correct transitions
because it is a GABAergic drug with known anxiolytic effects (Akwa et
al., 1999; Bitran et al., 2000); however, we observed an antagonistic ef-
fect, with the lowest and highest doses decreasing that parameter. It has
been suggested that several GABAA modulators have biphasic effects,
with low doses increasing negative effects, such as anxiety, and higher
doses decreasing them. This biphasic effect is observed after
allopregnanolone treatment in aggression (Miczek et al., 1997) and
avoidance/anxiety behavioral tests (Beauchamp et al., 2000). Our re-
sults may agree with part of this biphasic effect, because the lowestdose decreased the percentage of correct transitions, which is a predic-
tor of an anxiogenic effect.
The GABAA receptor is composed of ﬁve subunits, and its function
depends on combinations of these subunits (α1‐6, β1‐3, γ1‐3, δ, ε, π,
ο and ρ1‐3) (Hedblom and Kirkness, 1997; Hevers and Luddens,
1998; Mehta and Ticku, 1999). It was reported that allopregnanolone
increases the expression of γ2 subunit mRNA in the hippocampus
after intrahippocampal infusion (Nin et al., 2008). Also, it is known
that mice that are heterozygous for the γ2 subunit of GABAARs
(γ2+/) exhibit a modest functional deﬁcit in GABAA-R (Crestani
et al., 1999), accompanied by depressant-like symptoms, observed
in the forced swim and in the tail suspension tests (Shen et al.,
2010). In the same direction, γ2 L GABAA receptor subunits increase
during pregnancy with concomitantly higher levels of circulating
allopregnanolone in the cerebral cortex and hippocampus (Concas
et al., 1999). In the present study, we also observed an increase in
γ2 expression in the right hippocampus at the same dose that im-
proved behavioral deﬁcits. The δ subunit of the GABAA receptor has
been described to play a pivotal role in neurosteroid modulation,
and its absence prevents inhibitory synaptic currents in certain
brain cells (Vicini et al., 2002). After 48 h of allopregnanolone treat-
ment, there is an increase in the protein expression of the δ GABAA
subunit in the hippocampus of female rats (Shen et al., 2005). The
present study also showed that there was an increase in the δ
GABAA subunit mRNA expression in the right hippocampal hemi-
sphere of male rats after the allopregnanolone treatment dose that
reversed depressant-like behaviors. In the present case, the biochem-
ical analyses were performed in both brain hemispheres, and the in-
crease in δ and γ2 subunit expression after allopregnanolone
treatment was observed in the right hemisphere. Compared with
the study in females (Shen et al., 2005), in the present study, when
the mRNA data from both hemispheres is combined, there is still an
overall increase in expression of the δ and γ2 subunits. Previous stud-
ies from our group have shown that γ2 GABAA receptor subunit gene
expression increases in the right hemisphere compared with the left
one after allopregnanolone treatment (Nin et al., 2008). Asymmetri-
cal changes in brain biochemistry may also be present in mood disor-
ders in humans (Soares and Mann, 1997). Mood disorders, such as
bipolar disorder and depression, are associated with right hemi-
sphere dysfunction (Caligiuri et al., 2004; Tranel et al., 2002), and
hemispheric asymmetry has also been observed in animal behavioral
studies (Orman and Stewart, 2007; Sullivan, 2004). In addition, other
receptors, such as the Ν-methyl-D-aspartate receptor, and some of its
subunits, have higher right hemisphere subunit density in the mouse
hippocampus (Kawakami et al., 2003; Wu et al., 2005). This phenom-
enon is not observed for GABAA receptors, which exhibit symmetrical
expression in untreated animals. Moreover, the asymmetry observed
here is only present in the animals in which the depressant-like state
was reversed, suggesting a drug induction asymmetry and not a dis-
order induction asymmetry. All of this information may imply that
the allopregnanolone antidepressant effect is not only related to the
altered abundance of certain receptors in different areas but also to
the laterality of this change. The use of neurosteroids in the treatment
of mood disorders area currently under investigation. Some synthetic
neurosteroids has been tested with respect to their therapeutic
potential as ganaxolone, alphaxalone and minaxolone (reviewed
in Schüle et al., 2011). Thus, studies exploring the mechanism of ac-
tion of allopregnanolone are important tool to discovery of new
antidepressants.
5. Conclusion
This study provides evidence for the antidepressant-like effect
of intra-nucleus accumbens core infusion with allopregnanolone,
conﬁrming the participation of neurosteroids in the pathophysiology
of depression. The grooming microstructure analysis suggests that
365M.S. Nin et al. / Pharmacology, Biochemistry and Behavior 103 (2012) 359–366there may be a paradoxical biphasic effect at the lowest
allopregnanolone dose. Both δ and γ2 GABAA subunit expression in-
creases in the hippocampus may have a role in the mechanism of
the allopregnanolone antidepressant effect, providing information
not only regarding the directly infused region but also about changes
in other brain areas of the limbic system. Our ﬁndings point to asym-
metrical brain changes in GABAA receptor mRNA expression in ani-
mals treated with allopregnanolone. Further investigation should
attempt to detect which other brain areas are involved in this
GABAergic mechanism of action of allopregnanolone and whether
this asymmetry persists after chronic treatment.Acknowledgments
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